Professor Le Van Tan
Contact information
Research groups
Le Van Tan
Professor of Emerging Infectious Diseases
- OUCRU Interim Director
Emerging Infections
Professor Le Van Tan is Interim Director of our OUCRU programme.
Having benefited from Wellcome’s and Oxford’s long-term investments in Asia, he is totally committed to promoting the local science, capacity building and global heath. His long-term vision is to build sustainable expertise in Vietnam, Indonesia, Nepal and the wider region so that on-going and future emerging infectious disease challenges can be addressed from within the affected regions and communities, thereby making a positive impact on health of people around the world.
Professor Tan has worked across the disciplines, and collaborated with scientists across Wellcome funded MIPs in Southeast Asia and Africa, in Oxford, the region, and beyond.
His early work focused on pathogen discovery, which led to the discovery of a novel cyclovirus in 4% of Vietnamese patients with encephalitis.
He is the principal investigator of Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) Consortium. SEACOVARIANTS aims to develop and apply a multidisciplinary research platform in Southeast Asia for rapid assessment of the biological significance of SARS-CoV-2 variants, thereby informing coordinated local, regional and global responses to the COVID-19 pandemic and emerging infectious disease outbreaks. Most recently, he was awarded multiple grants from Wellcome, UKRI, Singapore PREPARE and Vietnam NAFOSTED to develop novel serological tools to enable early detection of zoonotic spillovers, and to assess the local population immune landscape against highly pathogenic avian influenza A virus H5N1.
Hand, Foot and Mouth Disease in Vietnam
Vietnamese and global strains of pegivirus
Recent publications
Central Nervous System Involvement by Novel Clade 2.3.2.1e H5N1 Avian Influenza Virus in a Pediatric Patient
Journal article
Nguyen PNT. et al, (2026), Open Forum Infectious Diseases, 13
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Journal article
Phong NT. et al, (2024), Wellcome Open Research, 9, 543 - 543
Correction: Aetiology and Potential Animal Exposure in Central Nervous System Infections in Vietnam
Journal article
Brindle HE. et al, (2024), EcoHealth, 21, 210 - 212
In Children, N-Methyl-D-Aspartate Receptor Antibody Encephalitis Incidence Exceeds That of Japanese Encephalitis in Vietnam
Journal article
Huong NHT. et al, (2024), Open Forum Infectious Diseases, 11
Post-pandemic T-cell Responses Cross-recognise Animal Sarbecoviruses with Spillover Potential
Preprint
Tan LV. et al, (2024)